• Research, Science, and Trials

  First FA Patients to Receive Leriglitazone in Ongoing FRAMES Trial

  Posted by FA Forums Moderator on June 24, 2019 at 10:28 am

  

  Researchers have started dosing patients with Minoryx Therapeutics’ leriglitazone in the ongoing Phase 2 FRAMES trial in patients with Friedreich’s ataxia. Read more about the trial here.

  What do you think of this news?

  replied 4 years, 10 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply